https://seekingalpha.com/article/4688345-annovis-bio-alzheimer-phase-2-3-topline-readout-puts-buntanetap-future-into-question?source=feed_all_articles
May 01, 2024 - Annovis faces financial challenges and may see a significant decline in stock prices. Find out why ANVS stock is a Sell.
0
sa:-308886040642586931
0
https://seekingalpha.com/news/4096265-inmune-bio-provides-update-alzheimers-candidate-xpro?source=feed_sector_healthcare
Apr 30, 2024 - INmune Bio's experimental Alzheimer's treatment XPro shows promising results in stabilizing cognitive states of patients in compassionate use program. Read more here.
0
sa:-5452782532398234899
0
https://seekingalpha.com/news/4095540-annovis-bio-alzheimers-tumbles-53-data-alzheimers-candidate-buntanetap?source=feed_sector_healthcare
Apr 29, 2024 - Annovis Bio's Alzheimers disease candidate, buntanetap, triggers trading halts as shares fall ~53%, indicating potential disappointment in trial results. Read more here
0
sa:-6607258486227355782
0
https://www.zacks.com/stock/news/2263665/entera-bio-ltd-entx-stock-slides-as-market-rises-facts-to-know-before-you-trade?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v2-2263665
Apr 26, 2024 - The latest trading day saw Entera Bio Ltd. (ENTX) settling at $1.98, representing a -1% change from its previous close.
zc:6031178259663694975
0
https://seekingalpha.com/news/4094442-takeda-leaves-industry-trade-group-bio?source=feed_sector_healthcare
Apr 25, 2024 - Takeda Pharmaceutical (TAK) joins Pfizer (PFE) in leaving the Biotechnology Innovation Organization, the top biotech lobbying group. Read more here.
0
sa:6032290131186852903
0
https://www.zacks.com/stock/news/2258103/why-the-market-dipped-but-entera-bio-ltd-entx-gained-today?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v3-2258103
Apr 18, 2024 - In the closing of the recent trading day, Entera Bio Ltd. (ENTX) stood at $2.24, denoting a +0.9% change from the preceding trading day.
zc:-1076406354595141893
0
https://seekingalpha.com/news/4091115-telesis-bio-stock-slips-amid-new-ceo?source=feed_sector_healthcare
Apr 18, 2024 - Telesis Bio (TBIO) stock slipped as the company promoted its Chief Operating Officer Eric Esser to the CEO role. Read more here.
0
sa:-1196246820117652749
0
https://seekingalpha.com/news/4091083-zura-bio-stock-jumps-on-plans-to-raise-1125m-in-private-financing?source=feed_sector_healthcare
Apr 18, 2024 - Zura Bio (ZURA) shares jumped around 12% after the immunology company entered into subscription agreements for a private placement.
0
sa:-3132837201734179163
0
https://www.zacks.com/stock/news/2257849/bio-rad-laboratories-bio-to-post-q1-earnings-what-awaits?cid=CS-ZC-FT-analyst_blog|earnings_preview-2257849
Apr 18, 2024 - The ongoing weakness in the biopharma end markets and tightening of sanctions against Russia is likely to have hurt Bio-Rad's (BIO) first-quarter 2024 growth.
zc:3120196327926588848
0
https://www.zacks.com/stock/news/2257012/2seventy-bio-tsvt-rises-more-than-50-in-3-months-here-s-why?cid=CS-ZC-FT-analyst_blog|price_surge_/_plunge-2257012
Apr 17, 2024 - The FDA's recent nod to 2seventy bio's (TSVT) Abecma in earlier lines of treatment for relapsed/refractory multiple myeloma is a positive. Also, the R&D asset divestiture to Regeneron is saving costs.
zc:-5865686420277375127
0